SREBF2 and colorectal carcinoma: In our study, we have shown that the activation of SREBP2-dependent cholesterol biosynthesis pathway was observed specifically in the liver metastases, but not in brain metastases and lymph node metastases, suggesting that metastatic CRC cells gain a liver-specific cholesterol metabolic characteristic.